The importance of endothelial cells in the cellular biology of blood vessels is well recognized; indeed, the intima is composed of a singular layer of endothelial cells embedded in an extracellular matrix. In general, three major functions are attributed to the endothelium: a metabolically active secretory tissue, an anticoagulant antithrombotic surface, and a barrier for blood constituents for blood vessel walls (1) . The importance of drug biotransformation in endothelial cells is now being recognized, and several investigators report cytochrome P450-dependent drug oxidation activity in endothelial cells; induction of endothelial CYP monooxygenases can be achieved upon treatment with various chemical agents (2) (3) (4) (5) (6) (7) .
The cell function of endothelium is complex and includes secretion of vasorelaxing and constricting factors, such as prostacyclin, endothelial-derived relaxing factor (EDRF), endothelial-derived hyperpolarizing factor (EDHF), endothelial-derived contracting factor (EDCF), or endothelin (8, 9) , coagulation factors such as factor VIII antigen, von Willebrand's factor, and plasminogen activator, matrix factors including collagen, glycosaminoglycans, fibronectin (10) , and metalloproteinases, as well as secretion of heparane and growth factors that regulate smooth muscle cell proliferation (11) . Endothelial cells are also well characterized for their production of NO, which is the predominant form of EDRF (8) , and are well known for their ability to metabolize plasma lipids, nucleotides, serotonine, catecholamines, bradykinin, and angiotensin-1 (12) .
Another important feature of endothelial cells is their antithrombotic surface and their interaction with leukocytes, the secretion of chemotactic molecules, and the presence of adhesion molecules including platelet endothelial cell adhesion molecule-1 (PECAM-1), intercellular cell adhesion molecule-1 (ICAM-1), ICAM-2, ELAM-1, vascular cell adhesion molecule-1 (VCAM-1), and GMP-140 (13, 14) . PECAM-1 is also expressed in human platelets, leukocytes, and intercellular junctions of endothelial cells (13) and is an important cell adhesion molecule. This particular antigen is of critical importance for cell migration, inflammatory processes, wound healing, and angiogenesis (15) ; PECAM-1 expression is regulated by several transcription factors including the c/EBP, NFB, GATA-2, and the CREB binding protein (16 -18) . There is additional evidence for the activator protein 2 (AP-2) and the plateletactivating factor to positively regulate gene expression of PECAM-1 (16, 21) . In contrast, interferon ␥, tumor necrosis factor ␣ (19), and thrombospondin-1 (20) reduce gene expression of PECAM-1.
The molecular mechanisms leading to endothelial dysfunction are ill understood, and transcription factors are likely to play a key role in this process. From a clinical point of view, endothelial dysfunction is governed by impaired endothelium-dependant relaxation (21) ; in the present study, long-term endothelial dysfunction is considered to be the result of a cascade of molecular events leading to cellular dedifferentiation.
We thus investigated the interplay of key transcription factors in cultures of endothelial cells, which were isolated from the aorta of rats to obtain a better understanding of the process of cellular dedifferentiation at the molecular level. To obtain functional parameters, gene regulation and protein activity of individual cytochrome P450 isoforms were investigated by measuring mRNA expression profiles of all major rat P450 isoforms and enzyme activity for the CYP1A1 monooxygenase substrate ethoxyresorufin. Expression of the transcription factors c/EBP␣ and GATA2 and that of the Oct-1 were investigated to elucidate their specific role during cellular dedifferentiation. Finally, gene expression of endothelial nitric oxide synthetase (eNOS) was used as a functional marker of endothelial cells; the modulating effects of Aroclor 1254, a well-known inducer of CYP monooxygenases (22) , were also studied in cultures of endothelial cells.
MATERIALS AND METHODS

Isolation and cultivation of endothelial cells
All animal procedures described in this report were approved by the local authorities.
Male Sprague Dawley and Lewis rats weighing 220 Ϯ 8 g were obtained from Charles River (Sulzfeld, Germany). Food and water were given ad libitum.
Anesthesia
Rats were anesthetized with Ketamin (anesthetic) and Rompun (muscle relaxant) with 0.1 ml of Ketamin per 100 g body weight and 0.05 ml of Rompun per 100 g body weight.
In addition, 2000 international units of heparin were given intraperitoneally prior to surgery.
The thorax was opened by surgical procedures, and the aorta thoracalis and abdominalis were carefully prepared and excised. After washing with phosphate-buffered saline (PBS) at 37°C, 4 -6 ml preheated M199 medium (Biochrom, Berlin, Germany) was pumped through the blood vessel. Thereafter, one end of the aorta was closed and 500 l of digestive enzyme solution (Trypsin/EDTA10ϫ, Life Technologies, Inc., Eggenstein, Germany) was pumped into the blood vessel. Then the aorta was closed completely and put into a petri dish filled with M199 medium. After an incubation period of 20 min, the aorta was opened, the enzyme solution was trapped in a small beaker, the aorta was rinsed with 5 ml DMEM (Biochrom) with 20% fetal calf serum (FCS; Biochrom), and the combined perfusate was centrifuged at 300 g and 4°C for 10 min. The supernatant was discarded and the cell pellet was suspended in 1 ml DMEM with 20% FCS, prednisolone 9.6 g/ml, glucagon 0.014 g/ml (Novo, Mainz, Germany), insulin 0.16 g/ml (Hoechst, Frankfurt, Germany), penicillin 200 U/ml, streptomycin 200 g/ml (Biochrom), heparin 15 U/ml, nonessential amino acids 10 l/ml, and bovine endothelial cell growth factor 30 g/ml (Roche, Mannheim, Germany). The cell suspension was placed in a 24-well plate coated with 1% gelatin. Cells were placed in an incubator at 37°C in a 5% CO 2 atmosphere and used after the third passage for further experiments.
Isolation and cultivation of hepatocytes
For isolation of hepatocytes, a modified method described by Seglen (23) was used.
In brief, after midline incision, the portal vein was cannulated and the liver was first perfused in situ with 100 ml calcium-free Krebs Ringer buffer (KRB) for 10 min, then with 100 ml KRB and EDTA (1 mmol/l). The liver was then perfused for 8 -10 min with KRB supplemented with collagenase type IV (Worthington, Freehold, N.J.) and 0.5 mM calcium chloride (Sigma, Deisenhofen, Germany). After perfusion, the liver capsule was gently removed and the dissolved liver tissue was filtrated through a nylon mesh (pore size, 100 m) and washed twice with the washing buffer (1000 ml Hanks balanced salt solution (PAA, Cölbe, Germany) supplemented with 2.4 g HEPES (Sigma) and 2 g bovine serum albumin (BSA; Sigma). The cell pellet was resuspended in William's E medium (Biochrom) supplemented with 5% FCS (Biochrom), 9.6 g/ml prednisolone, 0.014 g/ml glucagon (Novo), 0.16 U/ml insulin (Hoechst), 200 U/ml penicillin, and 200 U/ml streptomycin (Life Technologies, Inc.).
Hepatocytes were counted in a hemocytometer in the presence of 0.04% Trypan blue solution. Two million hepatocytes per dish were cultured between two layers of collagen in a modification of the method of Dunn et al. (24) and used for further experiments 48 h postisolation.
Modulation of gene expression
Modulation of gene expression was done with Aroclor 1254 (in DMSO), a complex chemical mixture (Ͼ80) of individual PCB isoforms and congeners at a concentration of 10 M for 24 h. Appropriate controls were treated with DMSO, but not with Aroclor 1254.
Flow cytometry
The fluorescence-activated flow cytometry assay is based on a CD31 rat fluorescein isothiocyanate (FITC) -conjugated anti-body and mouse IgG-FITC as a negative control (Serotec, Kidlington, U.K.). Initially, cells from a confluent layer were isolated with accutase (PAA) and washed with PBS containing 1% BSA. The resultant suspension was centrifuged at 300 g and 4°C for 5 min. The supernatant was discarded and the cell pellet was incubated with a CD31 antibody (Serotec) at 4°C in the dark for 30 min. After incubation with the CD31 antibody, cells were washed twice in 1 ml PBS containing 1% FCS, resuspended, and recentrifuged at 300 g and 4°C for 5 min. Again, the supernatant was discarded and cell pellets were resuspended in the latter buffer. Prior to the FACSCAN analysis, cell pellets were resuspended in 500 l PBS containing 1% BSA, and 10 g propidiumiodide was added. Analysis were carried out on a FACSalibur flow cytometer (Becton & Dickinson, Heidelberg, Germany) with an Argon laser at a 488 nm excitation wave length, the green FITC fluorescence at 530 nm and the red fluorescence of propidiumiodide at 585 nm.
EROD assay
This assay was done essentially as described by Grant et al. (25) . Control cells and cells treated with Aroclor 1254 were incubated with 2 M of ethoxy-resorufin-O-deethylase (EROD) and aliquots were removed from the cultures at 0, 1, 2, 3, and 7 h. Appropriate aliquots were taken from the samples, treated with ammonium acetate (200 mM, pH 4.5) and 100 U/ml of ␤-glucuronidase, and incubated at 37°C overnight. Five hundred microliters of glycine buffer (pH 10.3) was added to the sample containing ␤-glucuronidase and subsequent fluorometric analysis was carried out on a spectro-fluorophotometer (RF-1501, Schimadzu). The other aliquot was treated with ammonium acetate buffer (250 l) and glycine buffer (500 l), but without ␤-glucuronidase. The fluorometric analysis was done at an excitation wave length of 530 nm and an emission wave length at 585 nm. Calibration of the system was done with appropriate standards at a concentration range of up to 100 nM.
RNA and cDNA
RNA was isolated from endothelial cells using the SV total RNA Isolation System (Promega, Mannheim, Germany) according to the manufacturer's recommendation. Quality of isolated RNA was checked using a 1.0% agarose gel. Four micrograms total RNA from each sample was used for reverse transcription. RNA and random primer (Roche) were preheated for 10 min at 70°C. Then 1ϫ RT-AMV-buffer, dNTPs (Roche, 1.0 nM), 40 U RNase inhibitor (Stratagene, Amsterdam, Netherlands), 20 U AMV-RT (Promega) were added and diethyl pyrocarbonate-treated water was given to a final volume of 20 l. Reverse transcription was carried out for 60 min at 42°C and stopped by heating to 95°C for 5 min. The resulting cDNA was frozen at Ϫ20°C until further experimentation.
Thermocycler reverse transcription-polymerase chain reaction (RT-PCR)
For PCR amplification of cDNA, a 25 l reaction mixture was prepared containing 10ϫ polymerase reaction buffer, 3 mM MgCl 2 , 0.4 nM dNTPs(Roche), 400 nM concentration of the 3Ј and 5Ј specific primer (synthesized by Life Technologies, Inc.), 1 U Taq-polymerase (Roche), and 1 l of cDNA.
PCR reactions were carried out in a thermal cycler (T3, Biometra, Göttengin, Germany) using the following melting, annealing, and extension cycling conditions: denaturation for 30 s at 94°C, annealing for 60 s at 57°C, and extension for 60 s at 72°C (29 cycles) for CYPs, ␤-actin, and GAPDH. PCR conditions for GATA-2 were denaturation for 60 s at 94°C, annealing for 60 s at 62°C, and extension for 180 s at 72°C for 31 cycles. PCR conditions for c/EBP␣, Oct-1, and eNOS were denaturation for 45 s at 94°C, annealing for 45 s at 58°C, and extension for 60 s at 72°C for 30 cycles. Primer sequences are shown in Table 1 . PCR products were separated using a 1.8% agarose gel, stained with ethidium bromide, and photographed on a transilluminator. cDNA products were also sequenced by Seqlab (Göttingen, Germany).
Real-time semiquantitative RT-PCR
cDNA was diluted 1:10 with nuclease-free water and 1 l of the diluted cDNA was added to the Lightcycler-Mastermix (0.5 M of specific primer, 3 mM MgCl 2 , and 2 l Master-SYBR-Green, Roche). This reaction mixture was filled up with water to a final volume of 20 l. PCR reactions were carried out in a real-time PCR cycler (Lightcycler, Roche).
After an initial denaturation step at 95°C for 30 s, the PCR reaction was initiated with an annealing temperature of 57-62°C for 6 s, followed by an extension phase at 72°C for 11-33 s and a denaturation cycle at 95°C for 1 s. The PCR reaction was completed after a total of 35-45 cycles; at the end of each extension phase, fluorescence was observed and used for quantitative purposes. A melting point analysis was carried out by heating the amplicon from 65°C to 95°C and a characteristic melting point curve was obtained for each product.
In addition a serial dilution experiment was carried out (nϭ3) with cDNA produced from endothelial total RNA using a 1:10 dilution regiment to estimate the mRNA expression level of the specific genes. Control samples contained water instead of cDNA; note that oligonucleotide dimers were produced in the PCR mixture, but could easily be distinguished by the melting point analysis.
Statistical analysis
The Wilcoxon signed rank test was used and differences were considered significant at P Ͻ 0.05.
RESULTS
Morphology
Cultured endothelial cells were examined by inverse phase contrast microscopy (magnification, 20-fold). Figure 1A shows typical PECAM-1-positive endothelial cells, e.g., a regular, ordered, and densely packed confluent cell layer with condensed nuclei is observed. In contrast, PECAM-1-negative cells are disorganized, with large intercellular spaces and less prominent nuclei (see Fig. 1B ). Both cultures are the third passage of isolated aortic endothelial cells.
Flow cytometry
Endothelial cells were assayed for PECAM-1 expression by fluorescence-activated flow cytometry. Mouse IgG coupled to FITC was used to estimate the level of background fluorescence as shown in Fig. 2A .
In one experiment, over 95% of endothelial cells were positive for PECAM-1 (nϭ5); a typical result for PECAM-1-positive cultures is shown in Fig. 2C . Less than 0.5% of all PECAM-1-negative cell cultures (nϭ8) expressed this particular antigen (see Fig.  2B ). The viability of PECAM-1-positive and -negative cells was studied using the propidiumiodide stain; on average, Ͼ95% of endothelial cells were viable irrespective of the presence or absence of PECAM-1 expression.
When endothelial cells were isolated, cultivated, and passaged from Lewis rats Ͼ80% were PECAM-1 positive (nϭ8), whereas the success rate with Sprague Dawley rats was on average only 25-30% (nϭ9). This indicates a potential species difference for the successful isolation and subsequent cultivation of endothelial cells.
EROD activities as a marker substrate for cytochrome P450 monooxygenase
Ethoxyresorufin was incubated with endothelial and hepatocyte cell cultures (positive control) as described in Materials and Methods. As shown in Fig.  3A , PECAM-1-positive endothelial cells metabolized ethoxyresorufin in a time-dependent fashion and responded to treatment with Aroclor 1254, a wellknown inducer of this particular enzyme system. In strong contrast, PECAM-1-negative cells metabolized ethoxyresorufin only at minimal rates (see Fig. 3B ), the difference in activity being ϳ50-fold between both cultures. An approximate threefold higher rate of EROD activity could be determined if hepatocyte cultures were compared with PECAM-1-positive endothelial cell cultures 1 h after incubation (see Fig.  3C ). However, if incubations with hepatocyte cultures were continued for up to 7 h, a significant decline in the amount of EROD metabolites could be observed. When these samples were subjected to digestion with ␤-glucuronidase, a large amount of metabolites was recovered, indicating hepatocytes to be capable of catalyzing the glucuronidation of EROD oxidative products (see Fig. 3D ). This was not seen with endothelial cell cultures; indeed, endothe- lial cells may not be capable of catalyzing this particular type of reaction. Based on the results shown in Fig. 3D and within 1 h of incubation, ϳ50% of the overall metabolic activity can be accounted for by the glucuronidase activity in hepatocytes. After 2 h of incubation, roughly 80% accounted for the glucuronide metabolites, which increased to 90% and 95%, respectively, after 3 and 7 h. This shows that PECAM-1-positive or -negative endothelial cells are incapable of carrying out glucuronidation of EROD metabolites. Figure 4 depicts the gene expression profiles for CYP1A1, CYP1A2, CYP2B1/2, CYP2C11, CYP2E1, CYP3A1, CYP3A2, CYP4A1, and the housekeeping genes ␤-actin and GAPDH. A comparison of PECAM-1-positive and PECAM-1-negative cells provides clear evidence for CYP1A1 to be strongly expressed in PECAM-1-positive cells and hepatocyte cultures; in PECAM-1-negative cells, however, only a minor band can be detected, and this finding correlates with the EROD activity described above. CYP1A2 mRNA transcripts were detected in neither PECAM-1-positive or -negative endothelial cell cultures. In contrast, CYP2B1 was expressed in PECAM-1-positive cells, but again no mRNA transcripts could be detected for PECAM-1-negative cells with the PCR assay. CYP2C11 mRNA transcripts were detected in PECAM-1-positive cells, but PECAM-1-negative cells produced only a faint band in bromide-stained agarose gels. Expression of CYP2E1 mRNA was stronger in PECAM-1-negative than -positive cells. Neither CYP3A nor CYP4A1 gene transcripts could be detected in PE-CAM-1-positive or PECAM-1-negative cells, but the housekeeping genes ␤-actin and GAPDH were uniformly expressed throughout all cultures.
Gene expression studies
We investigated hepatocyte cultures as positive controls for CYP monooxygenase gene expression, and there is clear-cut evidence for CYP1A1 to be strongly expressed in controls and Aroclor 1254-treated cultures. ICYP1A2 mRNA transcripts were also detected. When compared to PECAM-1-positive cells, CYP2B1 mRNA was stronger expressed in hepatocyte cultures; in the case of CYP2C11, expression levels were equal for hepatocytes and PECAM-1-positive endothelial cells. The expression of CYP2E1 did not change in hepatocyte cultures upon treatment with Aroclor 1254, and mRNA transcripts for PECAM-1-negative endothelial cells and for hepatocyte cultures are similar. As shown in Fig. 4 , CYP3A1 and CYP4A1 are expressed at the mRNA level in rat hepatocyte cultures, and we can demonstrate that treatment with Aroclor 1254 enhanced the gene expression of the latter two genes ϳthreefold (see below). The housekeeping genes ␤-actin and GAPDH are similar and are uniformly expressed in controls and Aroclor 1254-treated cell cultures.
Real-time semiquantitative RT-PCR
The relative gene expression of CYP1A1 is shown in Fig. 5a , with CYP1A1 mRNA expression in control hepatocytes being set as the 100% value. When hepatocyte cultures were treated with Aroclor 1254 for 24 h, gene expression increases ϳfourfold and in PECAM-1-positive endothelial cells ϳsixfold. If this gene expression is compared with control PECAM-1-positive endothelial cells, however, an approximate threefold increase is observed. PECAM-1-negative cells did not respond to Aroclor 1254 treatment, and overall expression of individual genes except for CYP2E1 and the housekeeping genes was significantly suppressed when compared to the appropriate controls.
CYP1A2 mRNA was only detected in hepatocyte cultures, and its expression was induced ϳsixfold upon treatment with Aroclor 1254 (Fig. 5b) . CYP2B1/2 increased ϳtwofold in Aroclor 1254-treated hepatocyte cultures, but PECAM-1-positive endothelial cells did not respond to this treatment; with PECAM-1-negative endothelial cell cultures, gene expression of CYP2B1/2 was significantly reduced or even absent, as shown in Fig. 5c . Gene transcripts for CYP2C11 did not increase upon treatment with Aroclor 1254 irrespective of the cell type, e.g., hepatocyte or PECAM-1-positive endothelial cell cultures, but was significantly reduced in PECAM-1-negative cells (ϳ10% of original value, see Fig. 5d ).
CYP2E1 mRNA transcripts did not change upon treatment of hepatocyte cultures with Aroclor 1254, and a similar result was obtained when PECAM-1-positive and -negative endothelial cells were compared (Fig. 5e ). Unlike the other CYP genes, PECAM-1-negative endothelial cells had a strong expression of CYP2E1. As stated above, CYP3A and CYP4A transcripts were not expressed in any of the endothelial cells cultures, whereas in hepatocyte cultures a strong expression of the latter genes could be observed, especially upon treatment with Aroclor 1254, the relative increase being ϳthreefold (see Figs. 5f-h) . GAPDH gene expression was identical throughout all cell cultures and was not altered upon treatment with Aroclor 1254, as shown in Fig. 5i .
eNOS gene expression
The gene expression of eNOS was studied because of its unique expression in functional endothelium, and its expression differed dramatically when PE-CAM-1-positive and -negative cultures of endothelial cells were compared. The data shown in Fig. 6 and 7d provide strong evidence for eNOS gene expression to be reduced to 5% of control values.
There was also evidence for eNOS gene expression to be reduced to ϳ80% in Aroclor 1254-treated endothelial cell cultures, thus indicating a process of cellular deregulation on chemical treatment (see Fig. 7d ). 
Gene expression of nuclear transcription factors
The nuclear transcription factors GATA-2 and c/EBP␣ were chosen for their known role in gene regulation of PECAM-1. GATA-2 expression was reduced to ϳ10% of control values in PECAM-1-negative cells, as shown in Fig. 7a . A similar finding is obtained when c/EBP␣ gene expression is studied in PECAM-1-positive and -negative endothelial cell cultures; indeed, the gene expression of c/EBP␣ was reduced to ϳ10% of control values in cell cultures lacking PECAM-1 expression (see Fig.  7b ). Treatment of PECAM-1-positive endothelial cell cultures with Aroclor 1254 resulted in a significant increase of transcription factor mRNA expression (c/EBP␣ ϳ6-fold, GATA-2 ϳ11-fold) when compared with controls, but endothelial cells not expressing PECAM-1 did not respond to this treatment (Fig. 7a, b) .
Oct-1 gene expression
Oct-1 is a known silencer for the transcriptional activation of a wide range of physiologically important genes, including the CYP1A1 gene. We show in this study that Oct-1 gene expression is significantly elevated (ϳ14-fold) in PECAM-1-negative cells, but its expression is minimal in PECAM-1-positive cells (see Fig. 6 and Fig. 7c ). This finding correlates well with CYP1A1 mRNA expression, which was significantly reduced in endothelial cell cultures lacking PECAM-1 expression.
DISCUSSION
In this study we report the successful isolation and cultivation of endothelial cells from rat aorta, and we investigated the process of cellular dedifferentiation based on PECAM-1 and transcription factors gene expression, in addition to the gene expression of CYP monooxygenases and eNOS. We show that loss of PECAM-1 expression in arterial endothelial cell cultures strongly correlates with the induction of the transcriptional silencer Oct-1, and evidence is presented for a coordinate gene expression of the nuclear transcription factors GATA-2 and c/EBP␣ to play a major role in endothelial function. We also show that highly differentiated endothelial cells are capable of metabolizing (oxidizing) xenobiotic substances and that the expression of cytochrome P450 monooxygenases is regulated, at least in part, by the transcription factors GATA-2, c/EBP␣, and the transcriptional silencer Oct-1.
The rationale for the selection of the above-named transcription factors is based on their importance in regulating gene expression in the endothelium, e.g., PECAM-1, eNOS, and CYP monooxygenases (16, 26, 27) , and our experimental strategy encompassed a concomitant assessment of transcription factors and subsequent genes regulated by these transcription factors. In the case of GATA-2 and c/EBP, evidence is already available for PECAM-1 gene expression to be regulated, at least in part, by these transcription factors (16, 17) . GATA-2 also regulates ICAM-2 (28) and endothelin gene expression (29) , whereas Oct-1 was recently discovered as a silencer for CYP1A1 monooxygenases (30) and for the blood coagulating von Willebrand factor (31) . Figure 8 depicts known binding sites for transcription factors in the PE-CAM-1 and CYP1A1 gene (16, 27) . The differential gene expression of transcription factors in conjunction with flow cytometry and morphological examinations provides the rational for a potential mechanism of cellular dedifferentiation based on gene activation and silencing of a battery of genes by distinct transcription factors. We also show that whereas Oct-1 expression was massively increased. We thus propose a process of endothelial cellular dedifferentiation that is governed by the interplay of activation of Oct-1 and by silencing of other transcription factors and subsequent down-regulation of a battery of target genes, some of which were investigated in this study.
Endothelial dysfunction is of major importance in vascular disease. From a clinical point of view, atherosclerosis is a disease characterized by endothelial dysfunction, particularly impairment of endothelium-dependent relaxation (32) . The well-known vasospasm of diseased arteries appears to be related to a defective generation or delivery of NO (33) . Coronary spasm leading to myocardial infarction is extremely relevant clinically and could arise from this problem. We can show in this study that eNOS gene expression is almost completely abolished in dedifferentiated endothelial cells; likewise, the expression of CYP monooxygenases and particular of CYP1A1 is dramatically reduced as shown by our gene expression and protein activity data. The endothelium-derived hyperpolarizing factor (EDHF) is a cytochrome P450 1A-linked metabolite of arachidonic acid, as suggested by Adeagbo (7). Adeagbo perfused the rat mesenteric prearteriolar bed with various solutions and showed EDHF to most likely be a P4501A1-catalyzed metabolite of arachidonic acid. In a more recent study by Coceani et al. (33) , a contractoral tension of the ductus arteriosos is sustained by cytochrome P450-linked mechanisms. The authors isolated ductus from near-term fetal lambs and guinea pigs to investigate the effects on both muscle tone and endothelium for the formation of 1-aminobenzotriazol, a suicide substrate for cytochrome P450 monooxygenase reactions. The authors provide clear evidence that 1-aminobenzotriazol relaxation is due to suppression of a contractile mechanism and not to activation of prostaglandin and NO-mediated relaxing mechanism with cytochrome P450 being a key component in this reaction cycle (34) . Cytochrome P450 monooxygenase-regulated signaling of Ca 2ϩ entry in human and bovine endothelial cells was reported by Graier et al. (4) , who show that depletion of endothelial Ca 2ϩ stores activates microsomal P450 monooxygenase activity, which in turn synthesizes 5,6-epoxyeicosatrienoic acid. This arachidonic acid metabolite is in turn a second messenger for activation of endothelial calcium entry. The inhibition of NO-mediated responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450 in rat aortic rings, was studied by Li and Randt (6) . Clear evidence was obtained suggesting bioactivation of NOdonating substances (sodium nitroprusside and glyceryl trinitrate) by CYP monooxygenases.
One of the first reports on cytochrome P4501A1 activity and its induction in the endothelium of vertebrate heart was published by Stegemann and co-workers (2) . These authors show microsomal EROD activity to be similar to those induced in the liver of a teleost fish. With immunohistochemical methods, scup heart sections of ϳ2-4 m were stained with a monoclonal antibody; immunohistochemical studies showed P4501A1 to be detectable only in endothelial cells of the endocardium and coronary vasculature. Using human umbilical vein endothelial cells (HUVECs), Farin et al. (3) provided clear evidence for the expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of HUVECs. Using RT-PCR or Northern blot hybridization methods, a number of cytochrome P450 isoforms could be detected at the mRNA level (CYP2A1, CYP3A, CYP1A1, CYP1A2, but not CYP2B6). When these primary cell cultures were treated with either Arochlor 1254 and/or ␤-naphthoflavone CYP1A1, mRNA levels were increased but not the levels of CYP3A1 and CYP4A1 mRNA subsequent to PCB or ␤-naphthoflavone treatment (3). CYP1A1 and CYP2B was also detected in primary and immortalized rat brain endothelial cells, suggesting that cerebrovascular endothelial cells may express different P450 isoforms when compared to arterial cells of aortic endothelium (35).
In the present study, detailed information on the CYP gene expression of rat aortic endothelial cells was obtained and included positive identification of CYP1A1, CYP2B1/2, CYP2C11, and CYP2E1 mRNA in highly differentiated arterial endothelium; with the exception of CYP2E1, PECAM-1-negative cells basically lacked the gene expression of any of the CYP isoforms investigated. As shown above, CYP monooxygenases play an important role in vascular relaxation, and therefore the findings of the present study provide a comprehensive assessment of CYP gene expression during endothelial dysfunction.
In conclusion, the present investigation provides new insight into the molecular mechanisms of endothelial dysfunction based on the interplay of nuclear transcription factors and target gene expression. It is also evident that endothelial dysfunction is accompanied or even mediated by changes in oxidative metabolism. Endothelial dysfunction is governed not only by loss of eNOS gene expression, but also by a lack of PECAM-1 expression, a cellular adhesion molecule with great importance for vascular biology. Thus, endothelial dysfunction is governed by several events, including loss of eNOS and PECAM-1 expression. Whether the gene silencer Oct-1 is solely responsible for this process requires further investigation.
